Clinical Trials in Detroit

Showing 9521-9540 of 16,931 trials

Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study

NCT02481206

A multi-center, prospective, randomized controlled clinical trial with 1:1 assignment of treatment and control. This study will evaluate the impact of wearable cardioverter defibrillator use on sudden cardiac death in incident hemodialysis patients. The study will enroll up to 2,600 subjects. A maximum of 200 sites in the USA will be used for enrollment.

Sudden Cardiac DeathSudden Cardiac Arrest

Zoll Medical Corporation66 participantsStarted Jun 2015

Corona, California, United States • Downey, California, United States • Escondido, California, United States +28 more locations

COMPLETED11 miles

NBRST: Prospective Neo-adjuvant REGISTRY Trial

NCT01479101

The scope of this registry study is to measure chemosensitivity as defined by pCR (primary endpoint), or endocrine sensitivity as defined by partial response (decrease in longest tumor diameter or residual cancer burden category 1 (RCB1), a primary endpoint for neo-adjuvant endocrine therapy and a secondary endpoint for neoadjuvant chemotherapy), metastasis-free survival and relapse-free survival(secondary endpoints) in molecular subgroups, determined by the established MammaPrint, BluePrint, Targetprint and Theraprint profiles in addition to possible novel expression profiles.

Breast Cancer

Agendia1,142 participantsStarted Jul 2011

Glendale, Arizona, United States • Scottsdale, Arizona, United States • Berkeley, California, United States +73 more locations

Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study

NBRST: Prospective Neo-adjuvant REGISTRY Trial

Find Trials by Condition in Detroit

Vest Prevention of Early Sudden Death Trial and VEST Registry

Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury (ASCI)

Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)

A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD

Zenith Alpha™ Abdominal Endovascular Graft

A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma

A Prospective, Multi-Center Evaluation of the ECHELON CIRCULAR Powered Stapler in Left-Sided Colorectal Anastomoses

A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response.

Study to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII

Study of ANAVEX2-73 in Patients With Rett Syndrome

A Study of LY2157299 in Participants With Hepatocellular Carcinoma

Dose-escalation Study of Birinapant and Pembrolizumab in Solid Tumors

Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD)

Biomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal Photophoresis

Comparison of Human Embryo Development Using Sequential and Single Media With Time-lapse Imaging

Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function

Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection